Monitor blood pressure weekly as weight loss may require blood pressure medication adjustment
On procedures, the FDA found that Novo Nordisk's internal protocol allowed adverse drug experiences to be rejected if the reporter believed events were unrelated to the drug directly contradicting FDA regulations requiring all serious and unexpected events to be reported regardless of suspected causality
GLP-1 agonists, such as semaglutide (Wegovy) and tirzepatide (Mounjaro), work by mimicking natural hormones that regulate appetite, blood sugar, and digestion
This isn't just about weightit's about getting your life back.
"These drugs are inherently complex to compound safely, and the risks they pose to patient safety far outweigh any benefits," Novo Nordisk said in a statement
These side effects have led to chronic pain, nausea, vomiting, and, in some cases, life-threatening conditions like intestinal blockages